Stay updated with breaking news from Jerome Ritz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A team led by researchers from Mass Eye and Ear, a member of Mass General Brigham, reports the results of a phase I trial of a revolutionary stem cell treatment called cultivated autologous limbal epithelial cell transplantation (CALEC), which was found to be safe and well-tolerated over the short term in four patients with significant chemical burns in one eye.
Researchers took stem cells from a patient’s healthy eye and used them to help regrow tissue in a damaged eye.
/PRNewswire/ -- L7 Informatics, provider of the leading unified platform for integrated data and workflow solutions for the life sciences industry, announces...
Investegate announcements from Smart Immune, Smart Immune appoints world-leading experts to its Scientific Advisory Board
Smart Immune appoints world-leading expertsto its Scientific Advisory Board PARIS, France, July 28, 2022 - Smart Immune SAS, a clinical-stage biotechnology company developing ProTcell, a thymus-empowered